Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27555136 | 0.90 | CYP2D6 (0.33) | NAAA | |
| SCHEMBL4870836 | 0.85 | CYP1A2 (0.38) | NAAAEPHX1EPHX2CYP1A2 | |
| SCHEMBL28513740 | 0.85 | NAAA (0.40) | NAAAEPHX1EPHX2 | |
| SCHEMBL16398522 | 0.84 | AKR1B1 (0.41) | NAAA | |
| SCHEMBL2553560 | 0.81 | NAAA (0.42) | NAAAEPHX1EPHX2 | |
| SCHEMBL11453750 | 0.81 | CYP2D6 (0.34) | NAAAEPHX1EPHX2 | |
| SCHEMBL28514798 | 0.80 | NAAA (0.39) | NAAAEPHX1EPHX2 | |
| SCHEMBL8735246 | 0.80 | NAAA (0.39) | NAAAEPHX1EPHX2 | |
| SCHEMBL8736628 | 0.80 | NAAA (0.39) | NAAAEPHX1EPHX2 | |
| SCHEMBL105616 | 0.78 | GPR84 (0.46) | NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114426597-A | Preparation method of olefin polymerization catalyst component and prepared olefin polymerization catalyst component | 中国石油化工股份有限公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-114426609-A | Solid catalyst component for olefin polymerization and catalyst system | 中国石油化工股份有限公司 | 2022-05-03 | — | — | CN | disclosed |
| WO-2022078492-A1 | MAGNESIUM-BASED SOLID AND CATALYST COMPONENT HAVING MULTIMODAL PORE DISTRIBUTION, AND PREPARATION METHODS THEREFOR | 中国石油化工股份有限公司 | 2022-04-21 | — | — | WO | disclosed |
| US-11136421-B2 | Solid catalyst component for use in olefin polymerisation, catalyst, and application thereof | BEIJING LIHE TECHNOLOGY LTD (CN) | 2021-10-05 | — | — | US | disclosed |
| US-20200071430-A1 | SOLID CATALYST COMPONENT FOR USE IN OLEFIN POLYMERISATION, CATALYST, AND APPLICATION THEREOF | BEIJING LIHE TECH LTD (CN) | 2020-03-05 | — | — | US | disclosed |
| US-20190169328-A1 | OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF | RENQIU LIHE TECH LTD (CN) | 2019-06-06 | — | — | US | disclosed |
| US-20170355792-A1 | OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF | RENQIU LIHE TECH LTD (CN) | 2017-12-14 | — | — | US | disclosed |
| CN-104736627-A | Propylene resin composition for retort pouch-packaging film | SUN ALLOMER LTD | 2015-06-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169328-A1 | OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF | COG2, GTF2I, POF1B | NAAA 4455/4885EPHX1 3610/4885EPHX2 2923/4885 |
| US-20170355792-A1 | OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF | COG2, COG7, COG4 | NAAA 3757/4885EPHX1 2500/4885EPHX2 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.